Drug intelligence / Profile preview

furosemide + spironolactone

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Furosemide + spironolactone is a fixed-dose combination of two diuretics used primarily to treat edema (fluid overload) associated with heart failure, liver cirrhosis, kidney disease, or lung disease, as well as for the management of hypertension in certain cases. Furosemide is a loop diuretic that inhibits sodium and chloride reabsorption in the thick ascending limb of the loop of Henle, leading to increased excretion of water and electrolytes. Spironolactone is a potassium-sparing diuretic and aldosterone antagonist that blocks mineralocorticoid receptors in the distal nephron, promoting sodium excretion while conserving potassium. The combination provides synergistic diuresis while minimizing potassium loss compared to furosemide alone[1][2][3][10].

Brand names
LasilactoneFruselacSpiromideMinilactoneAmifru-SAldostixAldolocLasfru SDiutonDilupDireticDiretic-DSEdelossEdeloss Plus
Other names
furosemide and spironolactone
02

Targets

PR (Progesterone receptor)GR (Glucocorticoid receptor)AR (Adrenergic receptors)MR (Mineralocorticoid receptor)ER (Estrogen receptor)

Beyond the preview

Go deeper on furosemide + spironolactone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on furosemide + spironolactone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call